Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Edelmira Velez"'
Autor:
Josep M. Piulats, Eva Fernandez Parra, Pablo Borrega, Nuria Romero-Laorden, Nuria Lainez, Jose Contreras, M Isabel Sáez, Ylenia Cendon, Kristina Ibáñez, Pablo Lapunzina, Elena Vallespin Garcia, Francisco Zambrana, Rocío García Domínguez, Javier Puente, Elena Castro, Edelmira Velez, Begoña P. Valderrama, Lucia Heras, Elena Almagro, David Olmos
Publikováno v:
Journal of Clinical Oncology. 36:247-247
247 Background: Germline DDR have been identified in up to 12% of mCRPC patients. Initial results from various retrospective series have reported discordant impact in clinical outcomes associated to these gDDR following conventional treatments. PRORE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc3792e1b95be0dcfc69664ca5aedac3
https://doi.org/10.1200/jco.2018.36.6_suppl.247
https://doi.org/10.1200/jco.2018.36.6_suppl.247
Autor:
Isabel Anton, Edelmira Velez De Mendizabal, Hermini Manzano, Eduard Batiste-Alentorn, E. Saigi, Antonieta Salut, J. M. Campos, A. Arcusa, Ferran Losa, Inmaculada Guasch
Publikováno v:
Anti-Cancer Drugs. 15:835-841
Our objective was to assess the antitumoral activity and toxicity of irinotecan (CPT-11) 60-min i.v. infusion every 2 weeks as second-line monotherapy of advanced colorectal cancer. Two doses were studied (250 and 200 mg/m 2 ) according to the risk o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8780627393270d9aee6436fe679eb1a
https://doi.org/10.1097/00001813-200410000-00003
https://doi.org/10.1097/00001813-200410000-00003
Autor:
María José Juan Fita, Constanza Maximiano Alonso, Daniel Castellano, Javier L. Puertas, Angel Rodriguez Sanchez, Alvaro Pinto, P. Borrega, Isabel Chirivella, Julio Jose Lambea Sorrosal, Edelmira Velez De Mendizabal, Jose-Luis Gonzalez-Larriba, Rocío García Domínguez, Luis Leon Mateos, Aranzazu Gonzalez del Alba, Martin Lázaro Quintela, José Carlos Villa Guzman, Jose Angel Arranz Arija, Begoña Perez-Valderrama, Gustavo Rubio, Raquel Luque
Publikováno v:
Journal of Clinical Oncology. 33:e15597-e15597
e15597 Background: The IMRCC prognostic model for mRCC treated with VEGF-targeted agents (Heng, JCO '09) has been externally validated (Heng, Lancet Oncol '13), however, pt treated with Pz were not...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96d85fba1b059a620a46d7a2d6f55c4e
https://doi.org/10.1200/jco.2015.33.15_suppl.e15597
https://doi.org/10.1200/jco.2015.33.15_suppl.e15597
Autor:
Joaquim Pérez de Olaguer, Miguel Cadena Méndez, Eugeni Saigí, Hermini Manzano, M. Nogué, Edelmira Velez De Mendizabal, Ferran Losa, P. Vicente, L. Cirera, Immaculada Guasch, Antonieta Salud, A. Galan, A. Arcusa, J. M. Campos, Pilar Escudero, Eduard Batiste-Alentorn, M. Boleda
Publikováno v:
European journal of cancer (Oxford, England : 1990). 41(15)
This randomised, open-label trial compared oral tegafur (FT)/leucovorin (LV) with the intravenous bolus 5-fluorouracil (5-FU)/LV as first-line chemotherapy for advanced colorectal cancer (CRC). Patients were randomised to receive oral FT 750 mg/m2/da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80a57a48dd67e65fd8479b2d6ae9e6f1
https://pubmed.ncbi.nlm.nih.gov/16214045
https://pubmed.ncbi.nlm.nih.gov/16214045
Autor:
Natalia Oraá Tabernero, Monserrat Sánchez Fuentes, Gustavo Ossola Lentati, Edelmira Vélez, Francisco Javier Cevas, Natalia del Pino
Publikováno v:
Psicooncologia, Vol 10, Iss 2-3, Pp 339-351 (2014)
Con el presente artículo, se pretende dar a conocer los tratamientos psicológicos eficaces en el cáncer de próstata que se han llevado a cabo hasta la actualidad. Para entender los tratamientos psicológicos, es importante conocer, aunque sea de
Externí odkaz:
https://doaj.org/article/58cbf278663c471e8898c87fe2ef1ca0